Johannes R Lemke

42PUBLICATIONS
330CO-AUTHORS
NeurogeneticsCancer geneticsGene expression (incl. microarray and other genome-wide approaches)Agricultural molecular engineering of nucleic acids and proteinsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Jul 02, 2026
Clinical impact of genetic testing in inherited kidney diseases.

|Jun 05, 2026
PRS-BC313 integration for tailored breast cancer prevention in female patients and their healthy relatives.

|Jan 28, 2026
Predictive value of seizure onset for gross motor dysfunction in individuals with pathogenic GABRB2 and GABRB3 variants.

Sebastian Ortiz, Leonardo Affronte, Chiara Bagliani

|Jan 07, 2026
Correction: GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy.

Johannes R Lemke, Andrea Eoli, Ilona Krey

|Jan 05, 2026
Memantine treatment in individuals with GRIN gain-of-function variants is associated with improvements in behavior, development, and seizure frequency.

Maike Karnstedt, Riley E Perszyk, Scott J Myers

|Oct 14, 2025
GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy.

Johannes R Lemke, Andrea Eoli, Ilona Krey

Pageof 7

Frequent Collaborators

11 joint publications

Rami Jamra

10 joint publications

Konrad Platzer

7 joint publications

Rikke S Møller

6 joint publications

Steffen Syrbe